Stock Analysis
- Brazil
- /
- Food and Staples Retail
- /
- BOVESPA:RADL3
Raia Drogasil Third Quarter 2024 Earnings: Revenues Miss Expectations
Raia Drogasil (BVMF:RADL3) Third Quarter 2024 Results
Key Financial Results
- Revenue: R$9.99b (up 15% from 3Q 2023).
- Net income: R$362.1m (up 37% from 3Q 2023).
- Profit margin: 3.6% (up from 3.0% in 3Q 2023). The increase in margin was driven by higher revenue.
All figures shown in the chart above are for the trailing 12 month (TTM) period
Raia Drogasil Revenues Disappoint
Revenue missed analyst estimates by 1.2%.
Looking ahead, revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Consumer Retailing industry in Brazil.
Performance of the Brazilian Consumer Retailing industry.
The company's shares are up 3.7% from a week ago.
Risk Analysis
We should say that we've discovered 1 warning sign for Raia Drogasil that you should be aware of before investing here.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About BOVESPA:RADL3
Raia Drogasil
Engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines in Brazil.